These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 30781916)

  • 1. On a Plasminogen Activator from Human Plasma.
    Diaz Batista A; Hernandez Solana G; Corral Almonte JF
    Thromb Haemost; 1979 Jul; 42(1):1607-1614. PubMed ID: 30781916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On a plasminogen activator from human plasma.
    Batista AD; Solana GH; Almonte JF
    Thromb Haemost; 1980 Feb; 42(5):1607-14. PubMed ID: 6899948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purification and some physico-chemical and enzymatic properties of tissue kallikrein from human urine].
    Rabinovich SE; Lobareva LS; Paskhina TS
    Biokhimiia; 1990 Sep; 55(9):1675-89. PubMed ID: 2078641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of an acid protease and vasopeptide kinins from Murphy-Sturm lymphosarcoma.
    Bedi GS; Balwierczak J; Back N
    Adv Exp Med Biol; 1983; 156 (Pt B)():705-26. PubMed ID: 6344582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Purification and properties of plasminogen activator from human blood plasma after sudden death].
    Petrenko OA
    Biokhimiia; 1978 Aug; 43(8):1438-43. PubMed ID: 153771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of t-AMCHA and EACA on the plasma kallikrein system.
    Nakahara M
    Thromb Haemost; 1977 Feb; 37(1):104-10. PubMed ID: 576509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
    Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of human plasminogen activator and of a fraction of fibrinolytically active plasma enriched with this enzyme].
    Plastonova TK; Petrenko OA
    Vopr Med Khim; 1979; 25(3):302-7. PubMed ID: 156462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of a novel fibrinolytic enzyme from Streptomyces spp.
    Wang J; Wang M; Wang Y
    Chin J Biotechnol; 1999; 15(2):83-9. PubMed ID: 10719627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Various properties and kinetics of interaction of high and low molecular weight human kininogens with human plasma kallikrein].
    Nartikova VF; Egorova TP; Rets EV; Paskhina TS
    Biokhimiia; 1986 Mar; 51(3):463-71. PubMed ID: 3634630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purification of kininogen II (LMW) from human plasma].
    Díaz A; Henriques OB
    Acta Physiol Lat Am; 1976; 26(4):243-7. PubMed ID: 1032267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
    Harpel PC
    J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of kininogen on the activity of human blood serum kininogenase system].
    Datsenko VL; Iarovaia GA; Golosova NA; Lebedeva NV; Orekhovich VN
    Biokhimiia; 1977 Feb; 42(2):283-6. PubMed ID: 856307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H; Auel H; Riedel C
    Behring Inst Mitt; 1986 Feb; (79):263-71. PubMed ID: 2424424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):566-81. PubMed ID: 138962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW; Pawse AR
    Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of placental plasminogen activator (PPA).
    Kobayashi T; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.
    Sazonova IY; Aisina RB; Muhametova LI; Varfolomeyev SD
    Biochemistry (Mosc); 1999 Jan; 64(1):66-74. PubMed ID: 9986915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.